{"eventGroups":[{"description":"Participants were accrued at 50 mg/m\\^2 dose level after December 30, 2009 addendum. Participants to receive 50 mg/m\\^2 dinaciclib IV over 2 hours on day 1. Courses repeat every 21 days in the absence of disease progression or unacceptable toxicity.","id":"EG000","otherNumAffected":15,"otherNumAtRisk":15,"seriousNumAffected":7,"seriousNumAtRisk":15,"title":"Phase II: 50 mg/m^2"}],"frequencyThreshold":"0","otherEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 10","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15,"numEvents":3}],"term":"Hemoglobin decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 10","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15,"numEvents":1}],"term":"Vision blurred"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15,"numEvents":1}],"term":"Cheilitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15,"numEvents":2}],"term":"Constipation"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10","stats":[{"groupId":"EG000","numAffected":12,"numAtRisk":15,"numEvents":28}],"term":"Diarrhea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10","stats":[{"groupId":"EG000","numAffected":9,"numAtRisk":15,"numEvents":19}],"term":"Nausea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":15,"numEvents":8}],"term":"Vomiting"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 10","stats":[{"groupId":"EG000","numAffected":14,"numAtRisk":15,"numEvents":27}],"term":"Fatigue"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 10","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":15,"numEvents":3}],"term":"Fever"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 10","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15,"numEvents":2}],"term":"Pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15,"numEvents":1}],"term":"Peripheral nerve infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15,"numEvents":2}],"term":"Upper respiratory infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 10","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":15,"numEvents":8}],"term":"Alanine aminotransferase increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 10","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":15,"numEvents":18}],"term":"Aspartate aminotransferase increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 10","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15,"numEvents":1}],"term":"Bilirubin increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 10","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":15,"numEvents":9}],"term":"Leukocyte count decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 10","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":15,"numEvents":10}],"term":"Lymphocyte count decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 10","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":15,"numEvents":5}],"term":"Neutrophil count decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 10","stats":[{"groupId":"EG000","numAffected":11,"numAtRisk":15,"numEvents":19}],"term":"Platelet count decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 10","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15,"numEvents":1}],"term":"Anorexia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 10","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15,"numEvents":3}],"term":"Muscle weakness"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 10","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":15,"numEvents":11}],"term":"Peripheral motor neuropathy"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 10","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":15,"numEvents":19}],"term":"Peripheral sensory neuropathy"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 10","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":15,"numEvents":2}],"term":"Dyspnea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 10","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":15,"numEvents":6}],"term":"Pruritus"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 10","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":15,"numEvents":4}],"term":"Hypotension"}],"seriousEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 10","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15,"numEvents":1}],"term":"Dry eye syndrome"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 10","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15,"numEvents":1}],"term":"Eye pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 10","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15,"numEvents":1}],"term":"Photophobia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 10","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15,"numEvents":1}],"term":"Vision blurred"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":15,"numEvents":2}],"term":"Diarrhea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 10","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15,"numEvents":1}],"term":"Leukocyte count decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 10","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15,"numEvents":1}],"term":"Neutrophil count decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 10","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":15,"numEvents":2}],"term":"Platelet count decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 10","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":15,"numEvents":1}],"term":"Dyspnea"}]}